About Rhophlac4ITP.com

Rhophylac4ITP.com is an information resource for patients, families, and healthcare professionals seeking more information about ITP, and is brought to you by CSL Behring.

CSL Behring is a global leader in the plasma protein biotherapeutics industry, dedicated to treating rare and serious diseases and improving the quality of life of patients throughout the world. As a company with a long history of creating a stable supply of life-saving therapies, CSL Behring (formerly ZLB Behring and Aventis Behring) provides plasma-derived and recombinant products that are used in the treatment of individuals with ITP, hemophilia, and immune deficiency disorders as well as the treatment of cardiac surgery patients and burn victims.

CSL Behring has developed Rhophylac4ITP.com as part of our commitment to families affected by ITP. To learn more about how CSL Behring is focused on providing innovative, safe, and quality therapies for the customers they serve, please visit www.CSLBehring.com.

CSL Behring's Marketing, Medical Affairs, Regulatory, Legal, and IS departments are responsible for the content and development of Rhophylac4ITP.com. The information provided on the site is designed to support, not replace, the information provided through the relationship that exists between you and your physician.

Rhophylac4ITP.com does not host or receive funding from advertising.

For more information or if you have any questions, please contact us at webmaster@rhophylac4itp.com.